BRIEF-Appili Therapeutics Announces Change To Board Of Directors
BRIEF-Appili Therapeutics Announces Change To Board Of Directors
Nov 19 (Reuters) - Appili Therapeutics Inc APLI.TO :
路透11月19日電-Appili Treateutics Inc APLI.TO：
* APPILI THERAPEUTICS ANNOUNCES POSITIVE ONE YEAR CHALLENGE RESULTS FROM PRECLINICAL STUDY EVALUATING BIODEFENSE VACCINE CANDIDATE ATI-1701 AND CHANGE TO BOARD OF DIRECTORS
*APPILI Treeutics宣佈評估生物防禦疫苗候選ATI-1701的臨牀前研究的一年挑戰結果呈陽性，並更換為董事會成員
* APPILI THERAPEUTICS INC - JOSEF VEJVODA HAS RESIGNED FROM COMPANY'S BOARD OF DIRECTORS
*APPILI治療公司-Josef Vejvoda已辭去公司董事會職務
* APPILI THERAPEUTICS - MAKING CONTINUED PROGRESS ON MANUFACTURING AND IND-ENABLING ACTIVITIES TO ADVANCE ATI-1701 INTO CLINIC
*APPILI治療公司-在製造和支持IND的活動方面繼續取得進展，以推動ATI-1701進入臨牀
Source text for Eikon: ID:nBwbPQ2TRa Further company coverage: APLI.TO
Eikon的源文本：ID：nBwbPQ2TRa進一步的公司報道：APLI.TO
((Reuters.Briefs@thomsonreuters.com;))
(Reurs.Briefs@thomsonreurs.com；)
譯文內容由第三人軟體翻譯。